Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
PROCEPT BioRobotics Corporation - Common Stock
(NQ:
PRCT
)
36.47
+1.48 (+4.23%)
Streaming Delayed Price
Updated: 1:38 PM EDT, Oct 27, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
745,512
Open
35.80
Bid (Size)
36.31 (1)
Ask (Size)
36.46 (2)
Prev. Close
34.99
Today's Range
35.60 - 36.78
52wk Range
32.11 - 103.81
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares?
October 24, 2025
Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares?
Via
The Motley Fool
Beyond The Numbers: 4 Analysts Discuss PROCEPT BioRobotics Stock
October 15, 2025
Via
Benzinga
Performance
YTD
-56.1%
-56.1%
1 Month
-0.5%
-0.5%
3 Month
-32.6%
-32.6%
6 Month
-32.7%
-32.7%
1 Year
-59.9%
-59.9%
More News
Read More
PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025
October 15, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Assessing PROCEPT BioRobotics: Insights From 4 Financial Analysts
September 02, 2025
Via
Benzinga
Earnings Scheduled For August 6, 2025
August 06, 2025
Via
Benzinga
Where PROCEPT BioRobotics Stands With Analysts
April 25, 2025
Via
Benzinga
Earnings Scheduled For April 24, 2025
April 24, 2025
Via
Benzinga
4 Analysts Assess PROCEPT BioRobotics: What You Need To Know
February 26, 2025
Via
Benzinga
Earnings Scheduled For February 25, 2025
February 25, 2025
Via
Benzinga
Procept (PRCT) Q2 Revenue Jumps 48%
August 06, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
PROCEPT BioRobotics (PRCT) Earnings Transcript
August 06, 2025
Via
The Motley Fool
Topics
World Trade
PROCEPT BioRobotics Corp. (NASDAQ:PRCT) Reports Q2 2025 Revenue Growth but Misses Profitability Targets, Triggering After-Hours Decline
August 06, 2025
Via
Chartmill
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
August 06, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Uncovering Potential: PROCEPT BioRobotics's Earnings Preview
August 05, 2025
Via
Benzinga
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
July 24, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
July 23, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
July 21, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
July 14, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
April 29, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
April 24, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
April 24, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
April 10, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation
March 24, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada
March 14, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results
February 25, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Frequently Asked Questions
Is PROCEPT BioRobotics Corporation - Common Stock publicly traded?
Yes, PROCEPT BioRobotics Corporation - Common Stock is publicly traded.
What exchange does PROCEPT BioRobotics Corporation - Common Stock trade on?
PROCEPT BioRobotics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PROCEPT BioRobotics Corporation - Common Stock?
The ticker symbol for PROCEPT BioRobotics Corporation - Common Stock is PRCT on the Nasdaq Stock Market
What is the current price of PROCEPT BioRobotics Corporation - Common Stock?
The current price of PROCEPT BioRobotics Corporation - Common Stock is 36.47
When was PROCEPT BioRobotics Corporation - Common Stock last traded?
The last trade of PROCEPT BioRobotics Corporation - Common Stock was at 10/27/25 01:38 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.